Le Lézard
Classified in: Health, Covid-19 virus

URAC and 80 Organizations Call on DEA to Create Registry for Telemedicine Treatment of Substance Abuse

Washington, DC, Oct. 27, 2020 (GLOBE NEWSWIRE) -- On Oct. 26th, URAC joined 80 other organizations, led by the Alliance for Connected Care, in calling for the U.S. Drug Enforcement Administration (DEA) to implement a telemedicine special registration. This registration process would enable providers to safely prescribe controlled substances remotely.

The nation's response to COVID-19 has demonstrated the value of increased access to telemedicine to enable all qualified providers, including Community Mental Health Centers and addiction treatment facilities, to prescribe Medication Assisted Treatment (MAT) to patients with Opioid Use Disorder (OUD).

The failure to have a registry to allow for providers of telemedicine services to prescribe is a failure of the bureaucracy. On October 24, 2018, President Trump signed into law the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act. This legislation required the Attorney General, in consultation with the Secretary of Health and Human Services (HHS), to announce regulations specifying the circumstances for a special registration for telemedicine.

It has been a full two years since adoption of the SUPPORT Act and no meaningful progress has been made to further the execution of this critical policy.

Since the outset of the COVID-19 epidemic, the DEA, in partnership with the Substance Abuse and Mental Health Services Administration (SAMHSA), decided to allow remote prescribing of controlled substances using telemedicine without a prior in-person exam, regardless of the patient's location. While this update is vital to ensuring patients continue to have access to the care they require, such an emergency action is only required because the DEA and other federal agencies have failed to execute the requirements of the SUPPORT Act.

Given the worsening opioid overdose crisis, URAC and 80 stakeholder organizations urge the DEA to move forward with the telemedicine special registration process required by federal law that will enable SAMHSA waivered clinicians, Community Mental Health Centers and addiction treatment facilities to prescribe MAT to patients with OUD via telemedicine technology.

Read the full letter and list of undersigned organizations here.


These press releases may also interest you

at 16:00
McEwen Mining Inc. is pleased to report on the progress at the Fox Complex, where we are advancing a new mine on the Stock Property. Production is planned to start in the second half of 2025. Pre-construction activities of the Stock portal have...

at 16:00
First Mining Gold Corp. ("First Mining" or the "Company")  is pleased to announce the voting results from the Company's annual general meeting of shareholders held in Vancouver on June 20, 2024 (the "2024 AGM")....

at 15:30
Covia At Covia, we have highlighted several team members whose dedication and leadership have shaped the success of the company and the environment or their community. In this Insights Blog, we share the journey of Mike Foster, Senior Plant Manager...

at 15:15
SwiftDrip, an innovative mobile IV hydration company co-founded by CEO Derek Portea. In exciting news, SwiftDrip recently celebrated its rapid scaling to five-figure monthly revenues in just 90 days since its grand opening. This impressive...

at 14:25
First Trust Global Portfolios Management Limited ("FTGPM") announces the declaration of the quarterly distributions for the following sub-funds of First Trust Global Funds plc, ISIN Fund Name Frequency Dividend per Share...

at 14:05
Arch Insurance North America (Arch Insurance), a provider of short-term disability insurance and paid family and medical leave (PFML) coverage, today announced it has teamed up with the Disability Management Employer Coalition (DMEC) to present a...

News published on and distributed by: